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Joubert syndrome (JS) is an autosomal recessive disorder marked by agenesis of the cerebellar vermis, ataxia,
hypotonia, oculomotor apraxia, neonatal breathing abnormalities, and mental retardation. Despite the fact that
this condition was described 130 years ago, the molecular basis has remained poorly understood. Here, we identify
two frameshift mutations and one missense mutation in the AHI1 gene in three consanguineous families with JS,
some with cortical polymicrogyria. AHI1, encoding the Jouberin protein, is an alternatively spliced signalingmolecule
that contains seven Trp-Asp (WD) repeats, an SH3 domain, and numerous SH3-binding sites. The gene is expressed
strongly in embryonic hindbrain and forebrain, and our data suggest that AHI1 is required for both cerebellar and
cortical development in humans. The recently described mutations in NPHP1, encoding a protein containing an
SH3 domain, in a subset of patients with JS plus nephronophthisis, suggest a shared pathway.
Introduction
The mammalian cerebellum consists of two hemispheres
and a midline structure known as the “vermis,” which
is responsible for coordination of midline movements.
The most common disorder affecting the development of
this structure is Joubert syndrome (JS [MIM 213300]),
but the molecular determinants of this condition are
poorly understood. A key radiographic hallmark of JS
is the “molar tooth malformation” (MTM) seen on axial
brain imaging, which is a result of a malformed cere-
bellar vermis, thick and elongated cerebellar peduncles,
and a deep interpeduncular fossa (Maria et al. 1997).
There is signiﬁcant clinical heterogeneity in conditions
displaying cerebellar vermis hypoplasia and the MTM.
Some patients display the classic form of JS that includes
the MTM, ataxia, hypotonia, oculomotor apraxia, neo-
natal breathing abnormalities, and mental retardation
without extra-CNS involvement. Others also exhibit
ocular colobomas, polydactyly, liver ﬁbrosis, cystic dys-
plastic kidneys, retinal blindness, and/or nephronophth-
isis (NPHP [MIM 256100]). Distinct syndromes seen
with JS and the MTM have been identiﬁed and differ by
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their extra-CNS phenotype (Saraiva and Baraitser 1992;
Chance et al. 1999; Satran et al. 1999; Valente et al.
2003). Altogether, there appears to be no less than eight
of these distinct syndromes, and they are collectively
referred to as “Joubert syndrome and related disorders”
(JSRD) or “cerebello-oculo-renal syndromes” (CORS
[MIM 608091]). It is interesting that one of these syn-
dromes is marked by JS with the addition of cortical
polymicrogyria (Gleeson et al. 2004), a brain abnor-
mality characterized by excessive cortical folding, shal-
low sulci with walls that are fused in the deepest por-
tions, and a simpliﬁed four-layered or unlayered cortical
architecture (Barkovich et al. 1999; Ribacoba Montero
et al. 2002).
There is genetic heterogeneity that mirrors this clini-
cal heterogeneity seen in JS. Three causative loci have
been mapped, including JBTS1/CORS1 at 9q34.3 (Saar
et al. 1999), JBTS2/CORS2 at 11 centromere (Keeler
et al. 2003; Valente et al. 2003), and JBTS3/CORS3 at
6q23 (Lagier-Tourenne et al. 2004). The phenotypes of
the families mapping to JBTS1 and JBTS3 were similar,
displaying minimal extra-CNS involvement. One of six
patients mapping to the JBTS1 locus displayed retinal
dystrophy, and none showed NPHP or renal cysts, al-
though these were not speciﬁcally tested in all patients.
Likewise, only two of the seven JBTS3-mapped patients
displayed extra-CNS involvement—speciﬁcally, retinal
dysplasia. On the other hand, families mapping to JBTS2
displayed strong evidence of kidney involvement and
additional eye involvement. Of 11 patients, 6 displayed
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renal cysts or NPHP, 2 displayed retinal dysplasia, and
4 displayed optic coloboma. Together, the data suggest
that the JBTS1 and JBTS3 phenotypes usually do not
involve retinal or renal abnormalities, whereas these are
frequently seen in the JBTS2 phenotype.
Highlighting these genetic and phenotypic differences
is the recent ﬁnding of a mutation in NPHP1—a gene
mutated in some patients with NPHP or Senior Lo¨ken
syndrome (NPHP with retinal dystrophy)—in two sib-
lings with Senior Lo¨ken syndrome plus a mild form of
JS (Parisi et al. 2004). The NPHP1 gene encodes for the
nephrocystin protein, which contains an SH3 domain,
and has been implicated in intracellular signaling and
possibly ciliary function (Hildebrandt et al. 1997; Otto
et al. 2003).
Here, we show evidence that mutations in AHI1,
which encodes the Jouberin protein at the JBTS3 locus,
cause JS with polymicrogyria. Findings similar to these
were published in a recent article (Ferland et al. 2004),
in which mutations in AHI1 were seen with pure JS
with no retinopathy or supratentorial involvement. The
present work provides independent veriﬁcation of the
involvement of AHI1 in Joubert syndrome and suggests
a broader AHI1 phenotype that includes a role in cor-
tical development as well as cerebellar development.
Methods
Genotyping
Homozygosity mapping was performed on 18 consan-
guineous families that were previously excluded from
linkage to the JBTS1 and JBTS2 loci. Subjects were
mapped at six different markers spanning the JBTS3
locus, which was previously deﬁned by the markers
D6S1620 and D6S1699 (Lagier-Tourenne et al. 2004).
This study was performed in accordance with a Uni-
versity of California Human Subjects Committee–ap-
proved protocol.
After informed consent was obtained from all family
members, blood samples were drawn, and DNA was ex-
tracted, using standard procedures. Microsatellite mark-
ers were ampliﬁed by standard PCR with primers that
corresponded to sequence from the Human Genome
Browser. Heat-denatured PCR products were loaded onto
a 6% polyacrylamide gel containing urea and were run
by electrophoresis for 2.5 h at 40C. Bandswere visualized
using a standard silver-staining protocol (Promega).
Mutation Screening
Primers were designed for all coding exons and for at
least 50 bp of the intronic sequence that contained the
5′ and 3′ splice junctions, by use of the Primer3 program
(table A1 [online only]). PCRproductswere puriﬁedusing
an exonuclease I and shrimp-alkaline-phosphatase pro-
tocol and were sequenced using an ABI 3100 genetic
analyzer. Sequences were analyzed using Sequencher 4.1
software. Genomic sequence for human AHI1 was ob-
tained from theHumanGenomeBrowser (accessionnum-
bers AJ606362, AJ459825, and AK024085) and was
used for primer design.
Northern-Blot Analysis
Mouse probe DNA fragments for exons 6–10 were
designed as stated above, by use of sequence from the
mouse genome query of the Human Genome Browser
(accession numbers NM_026203, BB615071, and
BG297436). Probes were then labeled with [a-32P]dCTP,
by use of the Stratagene Prime-It RmT Labeling Kit. A
Clontech Multiple Tissue Mouse Northern (MTN) blot
was used to test for expression. Mouse tissues from post-
natal day 0 (P0) were used to isolate total mRNA by
Trizol and were similarly analyzed by northern analysis.
Northern blots were hybridized with the labeled probe,
by use of the Clontech MTN ExpressHyb protocol.
RT-PCR
Total RNA from whole brain, cerebellum, and cortex of
mice was isolated using a standard Trizol procedure, at
ﬁve different time points. First-strand cDNA was gen-
erated using Superscript II (Invitrogen) with RNase H
reverse transcriptase and oligo dT. cDNA was ampliﬁed
with primers for Jouberin exons 6–9 and for G3PDH,
by a 50-mL reaction with a ﬁnal primer concentration of
300 nM. Band intensities were quantiﬁed using Image-
Quant v.1.1 (Molecular Dynamics), and each band in-
tensity for Jouberin was standardized relative to its
G3PDH control.
Animal Subjects
All work was done in accordance with the University
of California–San Diego Animal Subjects Program.
Results
Mutations in AHI1 Are Seen in JS
Two families (10 and 115) showed linkage across the
entire JBTS3 interval, and one family (144) reﬁned the
candidate interval by showing homozygosity at a single
marker (D6S292), which suggests a double recombi-
nation (ﬁg. 1). Four genes within JBTS3 were chosen
for candidate analysis: AHI1, MAP7, OLIG3, and
KIAA1244. Of these, only AHI1 and MAP7 were ad-
jacent to D6S292. AHI1 mutational analysis of all cod-
ing exons in genomic DNA showed two frameshift mu-
tations in exon 8 (fsX270) and exon 10 (fsX408) and
one missense mutation in exon 10 (V443D). On the ba-
Figure 1 Mutations in AHI1, which encodes Jouberin, lead to cerebellar vermis aplasia, the MTM, and cortical polymicrogyria. A,
Genotypes of the three consanguineous families displaying evidence of linkage to the JBTS3 locus. Affected members of family MTI (molar-
tooth on brain imaging) 010 and MTI 115 display homozygosity for markers across the entire region (double red bar), whereas the affected
individual in family MTI 144 shows homozygosity for only a single marker (D6S292), which suggests a double recombination. Triangles with
question marks (?) represent unknown sex and affection status. B, Magnetic resonance imaging analysis of each of the JBTS3-linked families
corresponding to the pedigrees above. Top row, Axial images showing theMTI (blackened arrows), frontal polymicrogyria (unblackenedarrows),
and thin corpus callosum (arrow with C). Bottom row, Midline sagittal images showing horizontal superior cerebellar peduncle (arrowheads).
The asterisk (*) represents mega cisterna magna. Additional scans showing polymicrogyria in patient 144-2 can be found in ﬁgure A1 (online
only). C, Sequence chromatograms corresponding to the families above. Family MTI 010 displays a single-base insertion at position 787 in
exon 8, family MTI 115 displays a T1328A point mutation in exon 10, and family MTI 144 displays a 2-base deletion at positions 1188–89,
each of which leads to deleterious mutations in the Jouberin protein.
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Figure 2 Exonic structure of AHI1 and the Jouberin protein, including patient mutations. A, The gene encoded in ∼215 kb of genomic
DNA and that contains 31 exons, 2 of which are alternatively spliced, producing shorter isoforms. Patient mutations are indicated by arrows
and occur in exon 8 and exon 10. B, The predicted full-length human Jouberin protein gives a 1,196-aa message with seven WD40 repeats
and an SH3 domain.
sis of these results, we named the predicted protein
“Jouberin.”
Jouberin, Encoded by the AHI1 Gene, Is a Predicted
Signaling Molecule
The human Jouberin protein has three known isoforms
and contains sevenWD40 domains and one SH3 domain
(ﬁg. 2). Both human AHI1 and mouse Ahi1 have been
described elsewhere (Jiang et al. 2002), and human
AHI1 has been further characterized as having an N-
terminal coiled-coil domain (Ferland et al. 2004). Nu-
merous additional domains have been predicted in this
protein by use of ScanProsite analysis; among them are
multiple SH3-binding sites.
Database analysis and literature review showed that
the human AHI1 gene contains 31 exons; two that are
alternatively spliced (exon 24a and exon 27a), giving
rise to the different isoforms. Alternative splicing occurs
in both the 5′ UTR and the 3′ end of the Jouberin protein
after the WD repeats. The consequences of the 5′ UTR
alternative splicing are not readily apparent; however,
the 3′ splicing yields two isoforms of the protein that lack
either the SH3 domain or the far C-terminus of the pro-
tein. Exon 24a is used for a message that is ∼3.5 kb in
size. Exon 27a is used for a truncated isoform that pro-
duces a message mirroring the full-length ∼4.7-kb mes-
sage. An earlier publication (Jiang et al. 2002) reported
two other alternatively spliced exons, both of which en-
code alternate ORFs. However, no evidence for these
splice variants could be found in the public database by
querying the spliced ESTs or mRNAs. The function of
the gene is currently unknown, but the presence of the
SH3 domain suggests a role as a signaling molecule.
In the affected child of family 10, the frameshift mu-
tation in exon 8 is caused by the presence of an extra
cytosine (787insC) in the ORF and truncates the Joub-
erin protein at amino acid 270, which eliminates theWD
repeats and SH3 domain (ﬁgs. 1 and 2). The parents and
unaffected siblings carry this mutation. In the affected
child of family 144, the frameshift mutation in exon 10
is caused by a 2-base deletion (188-89delTG) in theORF,
truncating the protein at amino acid 408 and also elimi-
nating the WD repeats and SH3 domain. Both parents
and the unaffected sibling in this family carry this muta-
tion. In both affected individuals of family 115, the mis-
sense mutation in exon 10 changes a valine to aspartic
acid (V443D), a mutation that is not seen in the unaf-
fected family members. The valine is an evolutionarily
conserved amino acid, seen in all species that contain a
Jouberin orthologue for which sequence was available
(ﬁg. 3). The mutation also segregates with the phenotype
in this family. None of these mutations were observed
in 50 Middle Eastern controls.
Patients with Jouberin Mutations Display JS Plus
Polymicrogyria
The clinical features of the patients with Jouberin mu-
tations were examined in detail (table 1). They displayed
the clinical hallmarks of JS, and all had the MTM (ﬁg.
1). None of these patients showed evidence of renal in-
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Figure 3 Conservation of amino acids surrounding the mutation (V443D) in family 115. The mutated valine (V) is highlighted, and the
boxed area shows the sequence conservation among diverse species.
Table 1
Phenotypic Characteristics of Patients with AHI1 Mutations
CHARACTERISTIC
FINDING IN AFFECTED INDIVIDUALa
10-1 115-1 115-3 144-2
National origin Palestinian Kuwaiti Kuwaiti Turkish
Exon with mutation 8 10 10 10
Nucleotide changes 787insC T1328A T1328A 1188–89delTG
Alterations in coding sequence fsX270b V443D V443D fsX408b
MTM    
Cerebellar vermis aplasia/hypoplasia    
Breathing abnormalities  NA NA 
Ataxia/hypotonia    
Mental retardation    
Oculomotor apraxia    
Retinal involvement NA Rod-cone dysfunction Rod-cone dysfunction NA






Coloboma    
Kidney involvement    NA
Other    Atrial septal heart defect
a NA p not available;  p positive for the characteristic;  p negative for the characteristic.
b fs p frameshift.
volvement, but two, from the same family, displayed evi-
dence of retinal dysplasia. These data are consistent with
previous ﬁndings that this locus is not associated with
striking retinal or renal involvement, and they suggest
a role for this gene in cerebellar development.
These patients appear to have a supratentorial pheno-
type, with two patients in one family showing clear evi-
dence of polymicrogyria, a disorder of cerebral cortex
development in which there are supernumary small gyri.
There was also evidence in these families of corpus col-
losum abnormalities. Both affected members of family
115 display a thin corpus collosum and frontal poly-
microgyria, the single affected member of family 144
displays a thin corpus collosum and likely frontal poly-
microgyria, and the single affected member of family 10
displays enlarged lateral ventricles. These data suggest
a further role for the gene in development of the cortex.
Jouberin Is Expressed in Mouse Brain
during Development
To characterize the function of Jouberin, a northern
blot containing total mRNA was probed at a series of
embryonic time points with mouse exons 6–10 of Ahi1,
a region that is not known to be alternatively spliced.
Expression was ﬁrst evident at embryonic day 7 (E7)
and was also present at E11, E15, and E17, with the
most intense band occurring at E15 (ﬁg. 4). Each time
point showed a single band at ∼4.7 kb, which represents
the full-length variant of mouse Ahi1. Northern-blot an-
alysis was also performed to determine regional distri-
bution of expression for P0 mouse. The strongest levels
of expression were seen in the hindbrain and forebrain,
which showed two bands at ∼4.7 and 3.5 kb, corre-
sponding to the full-length isoform and the isoform lack-
ing the SH3 domain, respectively (Jiang et al. 2002).
These data suggest that Jouberin is expressed strongly
during periods of both cortical and cerebellar devel-
opment, consistent with the phenotypes seen in these
patients.
On the basis of the cortical and cerebellar phenotypes
in these families, expression was characterized in these
two regions separately, by RT-PCR analysis across the
developmental spectrum. Whole brain, cerebellum, and
cortex were isolated frommouse E14 through adulthood
at several stages and were tested for expression by use
of primers that ampliﬁed exons 6–9 to identify signal
984 Am. J. Hum. Genet. 75:979–987, 2004
Figure 4 Northern-blot analysis of Ahi1 (Jouberin) expression patterns in mice. A, Total mouse embryonic (E) 7–17 polyA mRNA was
probed with a fragment of Ahi1 corresponding to exons 6–10. Expression was ﬁrst evident at E7 and remained strong at E11, E15, and E17.
There is a single band at ∼4.7 kb (arrow) corresponding to the mouse Ahi1 gene from the Human Genome Browser. B, Total mRNA from
mouse organs, aged P0, probed with the same Ahi1 fragment. Strongest expression was shown in the hindbrain and forebrain, with two bands
visualized at 4.7 kb and 3.5 kb (arrows), corresponding to the two major splice variants (ﬁg. 3). Total mRNA loading control is shown below.
from only spliced message. Expression of Jouberin was
detected in whole brain at all time points analyzed (ﬁg.
5). Expression in cerebellum appeared maximal at E18
and P5, whereas expression in cerebral cortex appeared
maximal at E16 and E18. This expression corresponds
to the periods of maximal development of these two
brain regions, with cortical development preceding cere-
bellar development by several days in mice (Gofﬁnet and
Rakic 2000). Expression continued through adulthood,
but at lower levels. These data suggest that Jouberin
may exert its major effect during late embryonic
development.
Discussion
We present evidence that homozygous mutations in the
AHI1 gene lead to JS with polymicrogyria. Mutations in
AHI1 were found in patients with classic features of JS,
including the MTM and cerebellar vermis hypoplasia,
which are the current diagnostic criteria for JS. The ma-
jority of these patients did not display evidence of retinal
involvement, and none displayed renal involvement,
which suggests minimal overlap with the JBTS2/CORS2
phenotype. In addition, polymicrogyria was seen in two—
and possibly three—of four patients, whereas enlarged
cerebral lateral ventricles and hypoplasia of the corpus
callosum were seen in the remaining patients. This sug-
gests that a cerebral cortical phenotype exists among
patients with JS and with AHI1 mutations.
We recently identiﬁed a subtype of JS with polymicro-
gyria that was found in 2 of ∼100 patients with pos-
terior fossa malformations. These patients did not dis-
play mental retardation beyond the range expected in
JS, spasticity, microcephaly, or seizures, which would be
typical ﬁndings in patients with polymicrogyria (Gleeson
et al. 2004). In addition, none of the patients presented
here, who do not overlap with those published else-
where, reported these ﬁndings. However, there is other
evidence of a cerebral cortical phenotype among pa-
tients with linkage to the JBTS3 locus, since one patient
studied by Lagier-Tourenne et al. (2004) displayed spas-
ticity, microcephaly, and seizures. The data together sug-
gest that mutations in AHI1 can produce typical JS,
JS plus retinal involvement, or JS plus polymicrogyria
but that renal involvement is uncommon among these
patients.
The AHI1 gene (“Abelson helper integration-1”) was
named because of frequent integration of helper provirus
at this locus in Abelson murine leukemia virus–induced
lymphoma (Jiang et al. 2002). Involvement in leukemo-
genesis has been suggested by the high frequency ofAHI1
mutations seen in certain virus-induced murine leuke-
mias. Expression is high in most primitive hematopoietic
cells, with speciﬁc patterns of downregulation in different
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Figure 5 RT-PCR of Ahi1 (Jouberin) expression in mouse whole brain, cerebellum, and cortex, at different time points. Band-intensity
quantiﬁcation (standardized against G3PDH controls) revealed that Jouberin showed increasing and then decreasing expression as development
progressed. Maximum expression occurred in the cerebellum at E18 and P0, and maximum expression occurred in the cortex at E16 and E18.
Decreased but persistent expression in the adult was also evident. G3PDH controls are shown below. C p negative control.
lineages (Jiang et al. 2004), which suggests that down-
regulation is an important conserved step in primitive
normal hematopoietic cell differentiation. Although the
expression data that suggest a role for AHI1 in hema-
topoiesis is compelling, none of the patients presented
here showed evidence of hematopoietic abnormalities on
routine laboratory evaluations. Whether the gene plays
a critical or redundant role in hematopoiesis remains to
be determined.
We found that Ahi1 expression begins around E7 and
continues through adulthood. Northern-blot analysis
indicated the presence of two bands—a 4.7-kb and a 3.5-
kb isoform—that correspond to the known transcripts
from other organs, including brain (Jiang et al. 2002),
although only the longer isoform was identiﬁed by Fer-
land et al. (2004) by northern-blot analysis.
Jouberin homologues were identiﬁed in all mamma-
lian species examined, with high conservation in the
WD40 and SH3 domains but lower conservation in the
N- and C-termini. Highly conserved is the stretch of
amino acids surrounding the V443D that was found to
be mutated in family 115. An identical V443Dmutation
was also found by Ferland et al. (2004), who also iden-
tiﬁed two other premature stop codons among three
families with autosomal recessive JS without a cerebral
cortical phenotype (Ferland et al. 2004). Family 115
resides in Kuwait, whereas the family with the V443D
mutation studied by Ferland et al. (2004) resides in
Saudi Arabia, which, because of the relative proximity
of these countries, suggests a possible founder effect.
Analysis by ScanProsite indicates that this residue may
be part of a phosphorylation site by protein kinase C
(PKC) at the serine that is 4 aa in the N-terminal di-
rection (Jiang et al. 2002). Typically, there are hydro-
phobic amino acids such as valine after the serine in
PKC sites, and a mutation of this residue to an aspartic
acid might block this predicted phosphoprotein event.
Although this ﬁnding is speculative, it raises the pos-
sibility that Jouberin may be a phosphoprotein under
the control of PKC-related kinases.
The most highly conserved regions of Jouberin are
the SH3 domain and the WD40 repeats. These domains
are found in many signaling molecules, where they func-
tion as adaptor domains for protein-protein interactions.
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SH3 domains typically bind to PXXP motifs (known as
“SH3-binding domains”) to modulate these interactions.
Recently, we showed that mutations in NPHP1 are
found in a subset of patients with JS combined with
NPHP (Parisi et al. 2004), and it is interesting that both
of the encoded proteins of NPHP1 and the Jouberin
protein contain highly conserved SH3 domains. Addi-
tionally, Jouberin contains multiple PXXP domains,
which suggests that it may function with—or directly
bind to—the NPHP1 protein.
The NPHP gene family now consists of four genes of
diverse function, but it is becoming increasingly clear
that the NPHP proteins play critical roles in the function
of the cilia. The encoded proteins for NPHP1 and
NPHP2 colocalize to the primary cilia in renal epithelial
cells (Otto et al. 2003). Furthermore, loss-of-function
experiments in zebraﬁsh and mice suggest that these
proteins have roles in the establishment of left-right axis
determination in motile cilia (Mochizuki et al. 1998)
and in the pathogenesis of cystic kidney disease in non-
motile cilia (Otto et al. 2003). The NPHP data suggest
a possible role in cilia development, maintenance, or
transport, although the direct mechanism has yet to be
identiﬁed. The function of Jouberin remains to be de-
termined, but it will be interesting to test for its inter-
action with the NPHP genes and its involvement in cilia
function.
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